Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
VictrexVTXPF 71 Debt-to-Equity is 0.21 as of Mar. 2026, which is 133% above its 10-year median of 0.09. GuruFocus rates VTXPF with a GF Score™ of 71/100 and a GF Value™ of $14.71 (Significantly Undervalued). The stock has 10 warning signs investors should review. Among 1,421 Chemicals companies, Victrex ranks better than 63.34% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Victrex's Debt-to-Equity or its related term are showing as below:
VTXPF'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.02 Med: 0.09 Max: 0.21
Current: 0.21
During the past 13 years, the highest Debt-to-Equity Ratio of Victrex was 0.21. The lowest was 0.02. And the median was 0.09.
VTXPF's Debt-to-Equity is ranked better than 63.34% of 1421
companies
in the Chemicals industry
Industry Median: 0.36
vs VTXPF: 0.21
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Victrex Debt-to-Equity Related Terms
Victrex Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Victrex's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Chemicals subindustry, Victrex's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Victrex Debt-to-Equity vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Victrex's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Victrex's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Victrex (VTXPF) has a Debt-to-Equity of 0.21 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Victrex and its competitors. This is 133% above median its historical median of 0.09. Over the past decade, Victrex's Debt-to-Equity has ranged from 0.02 to 0.21. According to the industry distribution chart, Victrex ranks #521 out of 1421 companies in the Chemicals industry, placing it in the top 36.7%.
Is Victrex's Debt-to-Equity too high?
Victrex's current Debt-to-Equity of 0.21 is 133% above median its 10-year median of 0.09. Over the past 10 years, this metric has ranged from a low of 0.02 to a high of 0.21. The Chemicals industry median Debt-to-Equity is 0.36. Victrex's value of 0.21 is 41.7% below this industry median. Based on the distribution chart, Victrex ranks #521 out of 1421 companies in the Chemicals industry, which is above the industry midpoint. Overall, Victrex has a GF Score™ of 71/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Victrex's Debt-to-Equity compare to LIN and SHW?
According to the Chemicals industry distribution chart, Victrex ranks #521 out of 1421 companies for Debt-to-Equity. This puts Victrex in the upper half of its industry. The industry median Debt-to-Equity is 0.36. Victrex's value of 0.21 is 41.7% below this benchmark. Historically, Victrex's own Debt-to-Equity has ranged from 0.02 to 0.21 over the past decade. While the company's 10-year median is 0.09 vs. the industry median of 0.36, Victrex has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Chemicals company?
The median Debt-to-Equity among Chemicals companies is 0.36, based on 1,421 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Victrex's current Debt-to-Equity of 0.21 is 41.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Victrex and its competitors. For the Chemicals industry, the median Debt-to-Equity is 0.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Victrex's current Debt-to-Equity is 0.21, which is 133% above median its own 10-year median of 0.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Victrex stock overvalued right now?
Based on GuruFocus' analysis, Victrex (VTXPF) is currently considered Significantly Undervalued. The stock's GF Value™ is $14.71, compared to a current price of $9.12 — trading 38% below its estimated fair value. The current Debt-to-Equity is 0.21, which is 133% above median its 10-year median of 0.09 and 41.7% below the Chemicals industry median of 0.36. Victrex's overall GF Score™ is 71/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Victrex (VTXPF), the current Debt-to-Equity is 0.21 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Victrex (VTXPF) Overvalued in 2026?
Based on GuruFocus' analysis, Victrex stock appears to be undervalued.
The current stock price of $9.12 is trading 38% below its estimated GF Value™ of $14.71.
GuruFocus considers Victrex to be Significantly Undervalued.
Key valuation signals for VTXPF:
Debt-to-Equity: 0.21 (133% above median its 10-year median of 0.09)
GF Value™: $14.71 vs. price of $9.12 (38% below fair value)
Industry Position: 41.7% below the Chemicals median (#521 of 1421)
No single metric tells the full story. See the VTXPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Victrex PLC is a British specialty chemicals company whose business is based predominantly on manufacturing and creating solutions using polyetheretherketone, or PEEK, an ultra-high-performance lightweight plastic. The business has two segments. The Sustainable Solutions targets transportation, energy, electronics, and manufacturing, while the Medical Segment provides healthcare solutions for the implantable device markets. Geographically operates in the United Kingdom, Europe, the Middle East and Africa (EMEA), America, and Asia-Pacific. Its maximum sales are generated from the Middle East and Africa (EMEA).
71GF Score
Get the complete analysis for VTXPF
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VTXPF has been successfully added to your 
